Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
---|---|---|---|---|---|---|---|---|---|---|---|
MNK | Mallinckrodt plc | BISARO PAUL | Director | Jun 16, 2023 | Option Exercise | $1.28 | 3,689 | 4,722 | 71,131 | Jun 29, 2023, 06:51 PM | |
MNK | Mallinckrodt plc | BISARO PAUL | Director | Mar 14, 2023 | Buy | $8.47 | 5,000 | 42,330 | 74,820 | Mar 16, 2023, 04:05 PM | |
TXMD | TherapeuticsMD, Inc. | BISARO PAUL | Director | Aug 16, 2021 | Buy | $0.79 | 50,000 | 39,500 | 196,864 | Aug 18, 2021, 06:03 AM | |
TXMD | TherapeuticsMD, Inc. | BISARO PAUL | Director | Jun 04, 2020 | Buy | $1.14 | 50,000 | 57,000 | 50,000 | Jun 08, 2020, 04:10 PM | |
AMRX | Amneal Pharmaceuticals, Inc. | BISARO PAUL | Executive Chairman | May 07, 2019 | Option Exercise | $13.44 | 12,529 | 168,390 | 29,454 | May 09, 2019, 05:43 PM | |
AMRX | Amneal Pharmaceuticals, Inc. | BISARO PAUL | Executive Chairman | Mar 12, 2019 | Buy | $11.97 | 17,000 | 203,490 | 17,000 | Mar 12, 2019, 04:45 PM | |
AGN | Allergan plc | BISARO PAUL | Director | May 02, 2018 | Option Exercise | $151.07 | 1,985 | 299,874 | 263,729 | May 04, 2018, 06:18 PM | |
AGN | Allergan plc | BISARO PAUL | Director | May 01, 2018 | Option Exercise | $152.94 | 588 | 89,929 | 261,744 | May 03, 2018, 09:55 AM | |
AGN | Allergan plc | BISARO PAUL | Director | Mar 05, 2018 | Option Exercise | $148.73 | 2,921 | 434,440 | 262,332 | Mar 06, 2018, 06:51 PM | |
AGN | Allergan plc | BISARO PAUL | Director | Dec 29, 2017 | Option Exercise | $163.58 | 6,521 | 1,066,705 | 265,253 | Jan 02, 2018, 04:38 PM | |
AGN | Allergan plc | BISARO PAUL | Director | May 03, 2017 | Option Exercise | $243.76 | 214 | 52,165 | 232,824 | May 05, 2017, 06:26 PM | |
AGN | Allergan plc | BISARO PAUL | Director | May 04, 2017 | Option Exercise | $245.25 | 1,223 | 299,941 | 234,047 | May 05, 2017, 06:26 PM | |
AGN | Allergan plc | BISARO PAUL | Director | Mar 05, 2017 | Option Exercise | $245.63 | 2,862 | 702,993 | 233,038 | Mar 07, 2017, 04:53 PM | |
AGN | Allergan plc | BISARO PAUL | Director | Mar 02, 2017 | Sale | $246.68 | 70,000 | 17,267,561 | 274,226 | Mar 06, 2017, 06:59 AM | |
AGN | Allergan plc | BISARO PAUL | Director | Feb 02, 2017 | Option Exercise | $229.52 | 444 | 101,907 | 305,900 | Feb 06, 2017, 08:09 PM | |
AGN | Allergan plc | BISARO PAUL | Director | Feb 01, 2017 | Option Exercise | $229.32 | 10,516 | 2,411,529 | 308,867 | Feb 06, 2017, 08:08 PM | |
AGN | Allergan plc | BISARO PAUL | Exec Chairman | Feb 01, 2017 | Option Exercise | $229.32 | 10,516 | 2,411,529 | 188,867 | Feb 03, 2017, 08:32 PM | |
AGN | Allergan plc | BISARO PAUL | Exec Chairman | Aug 24, 2015 | Buy | $297.42 | 1,000 | 297,422 | 421,755 | Aug 24, 2015, 06:28 PM | |
ACT | Actavis plc | BISARO PAUL | Exec Chairman | Mar 05, 2015 | Option Exercise | $295.70 | 3,092 | 914,304 | 420,755 | Mar 09, 2015, 06:10 PM | |
ACT | Actavis plc | BISARO PAUL | Chair,Pres &CEO | May 09, 2014 | Option Exercise | $197.05 | 10,150 | 2,000,058 | 410,145 | May 13, 2014, 05:20 PM | |
ACT | Actavis plc | BISARO PAUL | Chair,Pres &CEO | Nov 11, 2013 | Sale | $158.73 | 40,921 | 6,495,569 | 417,638 | Nov 13, 2013, 08:19 PM | |
ACT | Actavis, Inc. | BISARO PAUL | President & CEO | Sep 30, 2013 | Option Exercise | $144.00 | 162,076 | 23,338,944 | 440,916 | Oct 02, 2013, 08:44 PM | |
ACT | Actavis, Inc. | BISARO PAUL | President & CEO | Aug 20, 2013 | Sale | $135.30 | 50,000 | 6,765,100 | 469,232 | Aug 22, 2013, 04:27 PM | |
ACT | Actavis, Inc. | BISARO PAUL | President & CEO | Aug 07, 2013 | Option Exercise | $70.54 | 851,261 | 60,051,531 | 843,293 | Aug 09, 2013, 03:59 PM | |
ACT | Actavis, Inc. | BISARO PAUL | President & CEO | Mar 05, 2013 | Option Exercise | $86.46 | 19,068 | 1,648,619 | 263,588 | Mar 07, 2013, 02:53 PM | |
ACT | Actavis, Inc. | BISARO PAUL | President & CEO | Mar 02, 2013 | Option Exercise | $85.54 | 24,683 | 2,111,384 | 282,656 | Mar 05, 2013, 07:16 PM | |
WPI | WATSON PHARMACEUTICALS INC | BISARO PAUL | President & CEO | Mar 14, 2012 | Option Exercise | $59.21 | 6,521 | 386,108 | 307,339 | Mar 16, 2012, 02:15 PM | |
WPI | WATSON PHARMACEUTICALS INC | BISARO PAUL | President & CEO | Feb 24, 2012 | Option Exercise | $58.17 | 16,759 | 974,871 | 251,927 | Feb 28, 2012, 12:18 PM | |
WPI | WATSON PHARMACEUTICALS INC | BISARO PAUL | President & CEO | Sep 04, 2011 | Option Exercise | $66.33 | 8,386 | 556,243 | 268,686 | Sep 06, 2011, 07:07 PM | |
WPI | WATSON PHARMACEUTICALS INC | BISARO PAUL | President & CEO | Mar 05, 2011 | Option Exercise | $56.79 | 11,933 | 677,675 | 277,072 | Mar 08, 2011, 04:24 PM |